A judge has signed off on a $38 million settlement in a shareholder class action against Mayne Pharma but has slashed a 27.9 per cent commission for the funder that backed the case. Victorian Supreme Court Justice Andrew Watson approved the settlement on 19 December, including $6 million in legal costs and a 25.7 per…
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
Accounting disciplinary body Chartered Accountants ANZ has dropped its investigation into former PwC tax partner Wayne Plummer, who was linked to the firm’s tax leaks scandal in 2023.
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories.
Shareholders in collapsed financial services firm Babcock & Brown have lost their bid to stay costs orders after losing a ten-year-old dispute.
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Two Queensland solicitors have scored partial wins in their decades-long disputes with the tax office because of the Administrative Appeals Tribunal’s “wholesale failure” to give proper reasons.
An intellectual property firm has lost its legal challenge to Apple’s bid to patent its method of authentication on electronic devices, including smartphones.
ASIC has won approval to bring claims against troubled regional airline Rex and four of its directors for allegedly misleading investors about the company’s financial position.